Mapping the capacities of fixed health facilities to cover people at risk of gambiense human African trypanosomiasis

Table 6 People at risk of gambiense HAT that are potentially covered by facilities with different types of treatment capabilities for HAT

Type of treatment	At-risk population potentially covered [%]
	≤ 1 hour travel time			≤ 3 hour travel time			≤ 5 hour travel time
	VH-H	M	L-VL	VH-H	M	L-VL	VH-H	M	L-VL
Tx1P	47	39	36	76	71	66	87	83	80
Tx2M	38	34	27	70	66	62	84	81	76
Tx2E	38	33	32	70	66	59	84	80	72
Tx2N	31	30	26	62	63	52	74	77	64

Tx1P: treatment of first-stage infection with pentamidine; Tx2M: treatment of second-stage infection with melarsoprol; Tx2E: treatment of second-stage infection with eflornithine; Tx2N: treatment of second-stage infection with nifurtimox-eflornithine combination therapy (NECT). VH: Very high risk; H: High risk; M: Moderate risk; L: Low risk; VL: Very low risk. People at risk are stratified by risk categories as defined in[7].

ISSN: 1476-072X